Exact Mass: 580.2916
Exact Mass Matches: 580.2916
Found 126 metabolites which its exact mass value is equals to given mass value 580.2916
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine
(S)-3-(4-Methoxyphenyl)-N-((S)-1-((R)-2-methyloxiran-2-yl)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-morpholinoacetamido)propanamido)propanamide
butanoic acid rel-(1aR,3S,3aS,4S,4aS,5R,6R,7aS,9R,9aS,9bR)-3,5-bis(acetyloxy)-3a[(acetyloxy)methyl]-1a,2,3,3a,4,4a,5,6,7,7a,8,9a,9b-tetradecahydro-7a,9-dihydroxy-1,1,6,9-tetramethyl-8-oxo-1H-cyclopropa[3,4]benzo[1,2-f]azulen-4-yl ester|kandovanol ester B
14-angeloyloxy-12-(cacalohastin-14-yl)cacalohastine
Tyr Arg Lys Asp
Tyr Lys Asp Arg
Cys Phe Arg Arg
Cys Arg Phe Arg
Cys Arg Arg Phe
Asp Lys Arg Tyr
Asp Lys Tyr Arg
Asp Arg Lys Tyr
Asp Arg Tyr Lys
Asp Tyr Lys Arg
Asp Tyr Arg Lys
Phe Cys Arg Arg
Phe Lys Thr Trp
Phe Lys Trp Thr
Phe Arg Cys Arg
Phe Arg Arg Cys
Phe Thr Lys Trp
Phe Thr Trp Lys
Phe Trp Lys Thr
Phe Trp Thr Lys
Lys Asp Arg Tyr
Lys Asp Tyr Arg
Lys Phe Thr Trp
Lys Phe Trp Thr
Lys Arg Asp Tyr
Lys Arg Tyr Asp
Lys Thr Phe Trp
Lys Thr Trp Phe
Lys Trp Phe Thr
Lys Trp Thr Phe
Lys Tyr Asp Arg
Lys Tyr Arg Asp
Arg Cys Phe Arg
Arg Cys Arg Phe
Arg Asp Lys Tyr
Arg Asp Tyr Lys
Arg Phe Cys Arg
Arg Phe Arg Cys
Arg Lys Asp Tyr
Arg Lys Tyr Asp
Arg Arg Cys Phe
Arg Arg Phe Cys
Arg Tyr Asp Lys
Arg Tyr Lys Asp
Thr Phe Lys Trp
Thr Phe Trp Lys
Thr Lys Phe Trp
Thr Lys Trp Phe
Thr Trp Phe Lys
Thr Trp Lys Phe
Trp Phe Lys Thr
Trp Phe Thr Lys
Trp Lys Phe Thr
Trp Lys Thr Phe
Trp Thr Phe Lys
Trp Thr Lys Phe
Tyr Asp Lys Arg
Tyr Asp Arg Lys
Tyr Lys Arg Asp
Tyr Arg Asp Lys
N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C141136 - ALK Inhibitor ASP3026 is a selective and orally active inhibitor of anaplastic lymphoma kinase (ALK). ASP3026 is a selective and oral active anaplastic lymphoma kinase (ALK) inhibitor with a IC50 value of 3.5 nM. ASP3026 can inhibit the phosphorylation of IGF-1R, STAT3, AKT and JNK proteins, and induce the cleavage of caspase 3 and PARP. It also inhibited ROS and ACK. ASP3026 can be used in anti-tumor research[1][2][3][4].
(2S)-3-(4-methoxyphenyl)-N-[(2S)-1-[(2R)-2-methyloxiran-2-yl]-1-oxo-3-phenylpropan-2-yl]-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide
N-[5-[1-[4-(4-acetylpiperazin-1-yl)cyclohexyl]-4-aminopyrazolo[3,4-d]pyrimidin-3-yl]-2-phenoxyphenyl]prop-2-enamide
N-[(2R,4aR,12aS)-5-methyl-2-[2-(3-morpholin-4-ylpropylamino)-2-oxoethyl]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-3-methoxybenzamide
N-[(2S,4aR,12aS)-5-methyl-2-[2-[3-(4-morpholinyl)propylamino]-2-oxoethyl]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-3-methoxybenzamide
N-[(2S,4aS,12aS)-5-methyl-2-[2-(3-morpholin-4-ylpropylamino)-2-oxoethyl]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-3-methoxybenzamide
N-[(2R,4aS,12aR)-5-methyl-2-[2-[3-(4-morpholinyl)propylamino]-2-oxoethyl]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-3-methoxybenzamide
N-[(2S,4aS,12aR)-5-methyl-2-[2-(3-morpholin-4-ylpropylamino)-2-oxoethyl]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-3-methoxybenzamide
N-[(2S,3R)-2-[[[(1,3-benzodioxol-5-ylamino)-oxomethyl]-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclohexanecarboxamide
N-[(2S,4aR,12aR)-5-methyl-2-[2-[3-(4-morpholinyl)propylamino]-2-oxoethyl]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-3-methoxybenzamide
N-[(2S,3S)-2-[[[(1,3-benzodioxol-5-ylamino)-oxomethyl]-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclohexanecarboxamide
N-[(2R,3S)-2-[[[(1,3-benzodioxol-5-ylamino)-oxomethyl]-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclohexanecarboxamide
N-[(2R,3R)-2-[[[(1,3-benzodioxol-5-ylamino)-oxomethyl]-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclohexanecarboxamide
N-[(2R,4aR,12aR)-5-methyl-2-[2-[3-(4-morpholinyl)propylamino]-2-oxoethyl]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-3-methoxybenzamide
N-[(2R,4aS,12aS)-5-methyl-2-[2-[3-(4-morpholinyl)propylamino]-2-oxoethyl]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-3-methoxybenzamide
4,15-bis(acetyloxy)-1-[(acetyloxy)methyl]-7,9-dihydroxy-5,9,12,12-tetramethyl-8-oxotetracyclo[8.5.0.0³,⁷.0¹¹,¹³]pentadecan-2-yl butanoate
(1s,2r,3s,4s,5r,8s,9r,10s,11s,12z,14s,17r)-2-(acetyloxy)-4,5,9,10-tetrahydroxy-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.0¹,¹⁷.0³,⁸]octadeca-6,12-dien-11-yl octanoate
(2s)-n-(5-carbamimidamido-1-oxopentan-2-yl)-1-[(2r)-2-{[(2r)-1,2-dihydroxy-3-(4-hydroxyphenyl)propylidene]amino}-4-phenylbutanoyl]pyrrolidine-2-carboximidic acid
(1r,3as,3br,5as,7s,9as,9bs,11r,11as)-7-{[(2r,3r,4r,5s,6r)-4,5-dihydroxy-3-methoxy-6-methyloxan-2-yl]oxy}-3a,5a,11-trihydroxy-11a-methyl-1-(5-oxo-2h-furan-3-yl)-dodecahydro-1h-cyclopenta[a]phenanthrene-9a-carbaldehyde
(1s,2e,7r,10z,12e,15r,16e,18z,21s,23r,24r)-23,24-dihydroxy-7-methyl-15-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-8,25-dioxabicyclo[19.3.1]pentacosa-2,10,12,16,18-pentaen-9-one
antiarojavoside
{"Ingredient_id": "HBIN016304","Ingredient_name": "antiarojavoside","Alias": "NA","Ingredient_formula": "C30H44O11","Ingredient_Smile": "CC1C(C(C(C(O1)OC2CCC3(C4CC(C5(C(CCC5(C4CCC3(C2)O)O)C6=CC(=O)OC6)C)O)C=O)OC)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1378","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}